South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Federal Judge Restores Funding for Gateway Rail Tunnel Project 
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions 
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links 
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Japan Election 2026: Sanae Takaichi Poised for Landslide Win Despite Record Snowfall 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
The United States is still struggling with the ongoing COVID-19 pandemic with millions infected and over 200,000 Americans dead from the disease. This week, Donald Trump announced his administration’s plan of distributing 150 million COVID-19 tests to Americans.
Trump announced on Monday that his administration plans to distribute 150 million rapid COVID-19 tests to Americans that were first promoted back in August. Formally unveiling the plan at the White House Rose Garden, Trump claimed that the tests were there to be made available to teachers who will need it, as many schools across the country have reopened physically while others have chosen to reopen virtually this year. The reopening was part of the administration’s push to return to normal even with the ongoing pandemic.
The tests are made by Abbott Laboratories and were touted as a possible game-changer to the pandemic. This sudden plan to release millions of COVID-19 tests is a shift in Trump’s previous assertion that more cases of COVID-19 were noted because there was more testing happening. Trump also said, in another sudden shift from his previous stances, that more efforts made to testing and noting asymptomatic cases in low-risk populations should not be cause for alarm or panic. 100 million of the tests would go to states and territories in support of efforts to reopen while 50 million would be allotted for those who are at the most risk of contracting the disease.
Despite these plans, federal guidelines on how these testing kits would be released to the American public have yet to be detailed. Some states and cities have yet to be fully on-board with the sudden distribution, and some have also expressed reluctance regarding its use.
Meanwhile, Trump faced off with former vice president Joe Biden in the first presidential debate, ending with the Republican incumbent perhaps unsurprisingly losing to the Democratic challenger. Even with this loss in the first debate, a piece by Chris Cillizza in CNN notes that during Trump’s debates with former Secretary of State Hillary Clinton in 2016, Trump lost all three of his presidential debates, despite claiming he had won every single one of them. Yet, Trump won the electoral college.
Exit polls from 2016 showed that at the time, ⅔ of the voters who said the debates mattered in their decision to vote for a candidate, Clinton won over Trump by four percentage points 50% to 46%. However, three in 10 voters who thought the debates did not matter in their vote, Trump overtook Clinton by a 17-point margin.
